rs27362

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001962.3(EFNA5):​c.126-74544C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0814 in 152,120 control chromosomes in the GnomAD database, including 1,081 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.081 ( 1081 hom., cov: 32)

Consequence

EFNA5
NM_001962.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.539

Publications

2 publications found
Variant links:
Genes affected
EFNA5 (HGNC:3225): (ephrin A5) Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFNA5NM_001962.3 linkc.126-74544C>T intron_variant Intron 1 of 4 ENST00000333274.11 NP_001953.1
EFNA5XM_011543250.4 linkc.-8080C>T 5_prime_UTR_variant Exon 1 of 5 XP_011541552.1
EFNA5NM_001410773.1 linkc.126-74544C>T intron_variant Intron 1 of 3 NP_001397702.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFNA5ENST00000333274.11 linkc.126-74544C>T intron_variant Intron 1 of 4 1 NM_001962.3 ENSP00000328777.6
EFNA5ENST00000504941.1 linkn.398-74544C>T intron_variant Intron 1 of 1 1
EFNA5ENST00000509503.1 linkc.126-74544C>T intron_variant Intron 1 of 3 5 ENSP00000426989.1
EFNA5ENST00000505499.1 linkn.56+4083C>T intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0813
AC:
12354
AN:
152002
Hom.:
1078
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.0170
Gnomad EAS
AF:
0.179
Gnomad SAS
AF:
0.0461
Gnomad FIN
AF:
0.0645
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00462
Gnomad OTH
AF:
0.0703
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0814
AC:
12383
AN:
152120
Hom.:
1081
Cov.:
32
AF XY:
0.0859
AC XY:
6384
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.191
AC:
7931
AN:
41470
American (AMR)
AF:
0.137
AC:
2090
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
59
AN:
3470
East Asian (EAS)
AF:
0.179
AC:
930
AN:
5182
South Asian (SAS)
AF:
0.0462
AC:
222
AN:
4810
European-Finnish (FIN)
AF:
0.0645
AC:
683
AN:
10586
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00462
AC:
314
AN:
68014
Other (OTH)
AF:
0.0691
AC:
146
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
503
1006
1510
2013
2516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0300
Hom.:
1350
Bravo
AF:
0.0943
Asia WGS
AF:
0.118
AC:
411
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.5
DANN
Benign
0.82
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs27362; hg19: chr5-106837754; API